Vistisen, Dorte
13 papers on CoChatORCID 0000-0001-5045-5351
Most cited papers
- Verified
Global healthcare expenditure on diabetes for 2010 and 2030
Zhang, P., Zhang, X., Brown, J., Vistisen, D., Sicree, R., Shaw, J., & Nichols, G. (2010) · Diabetes Research and Clinical Practice
Global Health Care IssuesHealth Systems, Economic Evaluations, Quality of Life
Cited by 1,145
- Verified
SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe
SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration, Pennells, L., Kaptoge, S., Østergaard, H. B., Read, S. H., Carinci, F., Franch-Nadal, J., Petitjean, C., Taylor, O., Hageman, S. H. J., et al. (2023) · European Heart Journal
Diabetes, Cardiovascular Risks, and LipoproteinsHealth Promotion and Cardiovascular Prevention
Cited by 329
- Verified
GLP-1 response to oral glucose is reduced in prediabetes, screen-detected type 2 diabetes, and obesity and influenced by sex: the ADDITION-PRO study
Færch, K., Torekov, S. S., Vistisen, D., Johansen, N. B., Witte, D. R., Jonsson, A., Pedersen, O., Hansen, T., Lauritzen, T., Sandbæk, A., et al. (2015) · Diabetes
Diabetes Treatment and ManagementPancreatic function and diabetes
Cited by 321
- Verified · note
Prediction of First Cardiovascular Disease Event in Type 1 Diabetes Mellitus: The Steno Type 1 Risk Engine
Vistisen, D., Andersen, G. S., Hansen, C. S., Hulman, A., Henriksen, J. E., Bech-Nielsen, H., & Jørgensen, M. E. (2016) · Circulation
Diabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 229
- Verified
Insulin Resistance Is Accompanied by Increased Fasting Glucagon and Delayed Glucagon Suppression in Individuals With Normal and Impaired Glucose Regulation
Færch, K., Vistisen, D., Pacini, G., Torekov, S. S., Johansen, N. B., Witte, D. R., Jonsson, A., Pedersen, O., Hansen, T., Lauritzen, T., et al. (2016) · Diabetes
Pancreatic function and diabetesDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 217
- Verified
Moving to an A1C-Based Diagnosis of Diabetes Has a Different Impact on Prevalence in Different Ethnic Groups
Christensen, D. L., Witte, D. R., Kaduka, L., Jørgensen, M. E., Borch-Johnsen, K., Mohan, V., Shaw, J. E., Tabák, A. G., & Vistisen, D. (2010) · Diabetes Care
Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research
Cited by 182
- Verified
Progressive decline in estimated glomerular filtration rate in patients with diabetes after moderate loss in kidney function-even without albuminuria
Vistisen, D., Andersen, G. S., Hulman, A., Persson, F., Rossing, P., & Jørgensen, M. E. (2019) · Diabetes Care
Chronic Kidney Disease and DiabetesAcute Kidney Injury Research
Cited by 167
- Verified
Evidence of a liver–alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids
Wewer Albrechtsen, N. J., Færch, K., Jensen, T. M., Witte, D. R., Pedersen, J., Mahendran, Y., Jonsson, A. E., Galsgaard, K. D., Winther-Sørensen, M., Torekov, S. S., et al. (2018) · Diabetologia
Pancreatic function and diabetesDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 119
- Verified
Pathophysiological characteristics underlying different glucose response curves: a latent class trajectory analysis from the prospective EGIR-RISC study
Hulman, A., Witte, D. R., Vistisen, D., Balkau, B., Dekker, J. M., Herder, C., Hatunic, M., Konrad, T., Færch, K., & Manco, M. (2018) · Diabetes Care
Diabetes, Cardiovascular Risks, and LipoproteinsPancreatic function and diabetes
Cited by 66
- Verified
Glucose patterns during an oral glucose tolerance test and associations with future diabetes, cardiovascular disease and all-cause mortality rate
Hulman, A., Vistisen, D., Glümer, C., Bergman, M., Witte, D. R., & Færch, K. (2018) · Diabetologia
Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research
Cited by 60
- Verified
Liraglutide changes body composition and lowers added sugar intake in overweight persons with insulin pump-treated type 1 diabetes
Schmidt, S., Frandsen, C. S., Dejgaard, T. F., Vistisen, D., Halldórsson, T., Olsen, S. F., Jensen, J. B., Madsbad, S., Andersen, H. U., & Nørgaard, K. (2022) · Diabetes, Obesity and Metabolism
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 29
- Verified
Treatment Modality–Dependent Risk of Diabetic Ketoacidosis in Patients with Type 1 Diabetes: Danish Adult Diabetes Database Study
Hoshina, S., Andersen, G. S., Jørgensen, M. E., Ridderstråle, M., Vistisen, D., & Andersen, H. U. (2018) · Diabetes Technology & Therapeutics
Diabetes Management and ResearchDiabetes Management and Education
Cited by 18
- Verified
Health‐related quality of life for normal glycaemia, prediabetes and type 2 diabetes mellitus: Cross‐sectional analysis of the ADDITION‐PRO study
Leal, J., Becker, F., Feenstra, T., Pagano, E., Jensen, T. M., Vistisen, D., Witte, D. R., & Jorgensen, M. E. (2022) · Diabetic Medicine
Health Systems, Economic Evaluations, Quality of LifeDiabetes Management and Education
Cited by 12
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free